{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:52:37Z","timestamp":1753887157641,"version":"3.41.2"},"reference-count":41,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The increase in the level of neutrophils following subclinical Cushing\u2019s disease is an uncommon clinical phenomenon that is characterized by insignificant biochemical or clinical evidence of hypercortisolism. In this study, we reported a 37-year-old female patient who presented with palpitations and fatigue, and showed increased neutrophils that were unaffected by anti-infection therapy. The patient was suspected of having a urinary tract infection because of occasionally with urinary frequency, urgency, increased procalcitonin, leukocytosis, and an increased proportion of neutrophils. The ineffectiveness of anti-infection therapy ruled out the possibility of urinary tract infection. Further examination of the bone marrow excluded the possibility of blood disease. However, the levels of blood cortisol and adrenocorticotropic hormone (ACTH) increased, and a magnetic resonance imaging examination revealed lesions in the sphenoidal sinus and sella area of the sphenoidal bone, which confirmed the relationship between increased glucocorticoids and increased neutrophils. This was further confirmed by follow-up surgery and pathological examination, which revealed silent corticotropin adenomas, which are characterized by the lack of biochemical or clinical evidence of hypercortisolism with positive immunostaining for ACTH.<\/jats:p>","DOI":"10.1515\/biol-2022-0540","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T16:31:43Z","timestamp":1674577903000},"source":"Crossref","is-referenced-by-count":0,"title":["Neutrophilia with subclinical Cushing\u2019s disease: A case report and literature review"],"prefix":"10.1515","volume":"18","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Tianjin Medical University General Hospital , Tianjin 300052 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Tianjin Medical University General Hospital , Tianjin 300052 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Tianjin Medical University General Hospital , Tianjin 300052 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songtao","family":"Shou","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Tianjin Medical University General Hospital , Tianjin 300052 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Tianjin Medical University General Hospital , Tianjin 300052 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"2023090109412530079_j_biol-2022-0540_ref_001","doi-asserted-by":"crossref","unstructured":"Abukhiran IA, Jasser J, Syrbu S. Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours. J Clin Pathol. 2020;73(6):310\u20133.","DOI":"10.1136\/jclinpath-2019-206340"},{"key":"2023090109412530079_j_biol-2022-0540_ref_002","doi-asserted-by":"crossref","unstructured":"Liew PX, Kubes P. The Neutrophil\u2019s role during health and disease. Physiol Rev. 2019;99(2):1223\u201348.","DOI":"10.1152\/physrev.00012.2018"},{"key":"2023090109412530079_j_biol-2022-0540_ref_003","unstructured":"Kumar V, Abbas AK, Aster JC. Robbins basic pathology E-Book. United Kingdom: Elsevier Health Sciences; 2017. p. 57\u201397."},{"key":"2023090109412530079_j_biol-2022-0540_ref_004","doi-asserted-by":"crossref","unstructured":"Hidalgo A, Chilvers ER, Summers C, Koenderman L. The neutrophil life cycle. Trends Immunol. 2019;40(7):584\u201397.","DOI":"10.1016\/j.it.2019.04.013"},{"key":"2023090109412530079_j_biol-2022-0540_ref_005","doi-asserted-by":"crossref","unstructured":"Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol. 2010;31(8):318\u201324.","DOI":"10.1016\/j.it.2010.05.006"},{"key":"2023090109412530079_j_biol-2022-0540_ref_006","doi-asserted-by":"crossref","unstructured":"Richards MK, Liu F, Iwasaki H, Akashi K, Link DC. Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway. Blood. 2003;102(10):3562\u20138.","DOI":"10.1182\/blood-2003-02-0593"},{"key":"2023090109412530079_j_biol-2022-0540_ref_007","doi-asserted-by":"crossref","unstructured":"Jing W, Guo X, Qin F, Li Y, Wang G, Bi Y, et al. G-CSF shifts erythropoiesis from bone marrow into spleen in the setting of systemic inflammation. Life Sci Alliance. 2021;4(1):e202000737.","DOI":"10.26508\/lsa.202000737"},{"key":"2023090109412530079_j_biol-2022-0540_ref_008","doi-asserted-by":"crossref","unstructured":"Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159\u201375.","DOI":"10.1038\/nri3399"},{"key":"2023090109412530079_j_biol-2022-0540_ref_009","doi-asserted-by":"crossref","unstructured":"Nakagawa M, Terashima T, D\u2019Yachkova Y, Bondy GP, Hogg JC, van Eeden SF. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation. 1998;98(21):2307\u201313.","DOI":"10.1161\/01.CIR.98.21.2307"},{"key":"2023090109412530079_j_biol-2022-0540_ref_010","doi-asserted-by":"crossref","unstructured":"Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932. Obes Res. 1994;2(5):486\u2013508.","DOI":"10.1002\/j.1550-8528.1994.tb00097.x"},{"key":"2023090109412530079_j_biol-2022-0540_ref_011","unstructured":"Chaudhry HS, Singh G. Cushing syndrome. Treasure Island (FL): StatPearls; 2022."},{"key":"2023090109412530079_j_biol-2022-0540_ref_012","doi-asserted-by":"crossref","unstructured":"Santos A, Granell E, G\u00f3mez-Ans\u00f3n B, Crespo I, Pires P, Vives-Gilabert Y, et al. Depression and anxiety scores are associated with amygdala volume in Cushing\u2019s syndrome: Preliminary study. Biomed Res Int. 2017;2017:2061935.","DOI":"10.1155\/2017\/2061935"},{"key":"2023090109412530079_j_biol-2022-0540_ref_013","doi-asserted-by":"crossref","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing\u2019s syndrome: an Endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526\u201340.","DOI":"10.1210\/jc.2008-0125"},{"key":"2023090109412530079_j_biol-2022-0540_ref_014","doi-asserted-by":"crossref","unstructured":"Nieman LK, Ilias I. Evaluation and treatment of Cushing\u2019s syndrome. Am J Med. 2005;118(12):1340\u20136.","DOI":"10.1016\/j.amjmed.2005.01.059"},{"key":"2023090109412530079_j_biol-2022-0540_ref_015","doi-asserted-by":"crossref","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing\u2019s syndrome. Lancet. 2006;367(9522):1605\u201317.","DOI":"10.1016\/S0140-6736(06)68699-6"},{"key":"2023090109412530079_j_biol-2022-0540_ref_016","doi-asserted-by":"crossref","unstructured":"Melmed S, Koenig R, Rosen C, Auchus R, Goldfine A. Williams textbook of endocrinology E-Book. United Kingdom: Elsevier Health Sciences; 2019.","DOI":"10.33029\/9704-4951-6-PEND-1-848"},{"key":"2023090109412530079_j_biol-2022-0540_ref_017","doi-asserted-by":"crossref","unstructured":"Deipolyi A, Karaosmano\u011flu A, Habito C, Brannan S, Wicky S, Hirsch J, et al. The role of bilateral inferior petrosal sinus sampling in the diagnostic evaluation of Cushing syndrome. Diagn Interv Radiol. 2012;18(1):132\u20138.","DOI":"10.4261\/1305-3825.DIR.4279-11.0"},{"key":"2023090109412530079_j_biol-2022-0540_ref_018","doi-asserted-by":"crossref","unstructured":"Jagannathan J, Smith R, DeVroom HL, Vortmeyer AO, Stratakis CA, Nieman LK, et al. Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease. J Neurosurg. 2009;111(3):531\u20139.","DOI":"10.3171\/2008.8.JNS08339"},{"key":"2023090109412530079_j_biol-2022-0540_ref_019","doi-asserted-by":"crossref","unstructured":"Lanzino G, Maartens NF, Laws Jr ER. Cushing\u2019s case XLV: Minnie G. J Neurosurg. 2002;97(1):231\u20134.","DOI":"10.3171\/jns.2002.97.1.0231"},{"key":"2023090109412530079_j_biol-2022-0540_ref_020","doi-asserted-by":"crossref","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, et al. Treatment of Cushing\u2019s syndrome: An Endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807\u201331.","DOI":"10.1210\/jc.2015-1818"},{"key":"2023090109412530079_j_biol-2022-0540_ref_021","doi-asserted-by":"crossref","unstructured":"Braun LT, Rubinstein G, Zopp S, Vogel F, Schmid-Tannwald C, Escudero MP, et al. Recurrence after pituitary surgery in adult Cushing\u2019s disease: a systematic review on diagnosis and treatment. Endocrine. 2020;70(2):218\u201331.","DOI":"10.1007\/s12020-020-02432-z"},{"key":"2023090109412530079_j_biol-2022-0540_ref_022","doi-asserted-by":"crossref","unstructured":"Tritos NA, Biller BMK. Current management of Cushing\u2019s disease. J Intern Med. 2019;286(5):526\u201341.","DOI":"10.1111\/joim.12975"},{"key":"2023090109412530079_j_biol-2022-0540_ref_023","doi-asserted-by":"crossref","unstructured":"Gadelha MR, Vieira Neto L. Efficacy of medical treatment in Cushing\u2019s disease: a systematic review. Clin Endocrinol (Oxf). 2014;80(1):1\u201312.","DOI":"10.1111\/cen.12345"},{"key":"2023090109412530079_j_biol-2022-0540_ref_024","doi-asserted-by":"crossref","unstructured":"Fountas A, Karavitaki N. Nelson\u2019s syndrome: An update. Endocrinol Metab Clin North Am. 2020;49(3):413\u201332.","DOI":"10.1016\/j.ecl.2020.05.004"},{"key":"2023090109412530079_j_biol-2022-0540_ref_025","doi-asserted-by":"crossref","unstructured":"Sahakian N, Castinetti F, Brue T, Cuny T. Current and emerging medical therapies in pituitary tumors. J Clin Med. 2022;11(4):955.","DOI":"10.3390\/jcm11040955"},{"key":"2023090109412530079_j_biol-2022-0540_ref_026","doi-asserted-by":"crossref","unstructured":"Pence A, McGrath M, Lee SL, Raines DE. Pharmacological management of severe Cushing\u2019s syndrome: the role of etomidate. Ther Adv Endocrinol Metab. 2022;13:20420188211058583.","DOI":"10.1177\/20420188211058583"},{"key":"2023090109412530079_j_biol-2022-0540_ref_027","doi-asserted-by":"crossref","unstructured":"Pivonello R, Ferrigno R, De Martino MC, Simeoli C, Di Paola N, Pivonello C, et al. Medical treatment of Cushing\u2019s disease: an overview of the current and recent clinical trials. Front Endocrinol (Lausanne). 2020;11:648.","DOI":"10.3389\/fendo.2020.00648"},{"key":"2023090109412530079_j_biol-2022-0540_ref_028","doi-asserted-by":"crossref","unstructured":"Ferriere A, Tabarin A. Cushing\u2019s syndrome: Treatment and new therapeutic approaches. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101381.","DOI":"10.1016\/j.beem.2020.101381"},{"key":"2023090109412530079_j_biol-2022-0540_ref_029","doi-asserted-by":"crossref","unstructured":"Bertagna X. Management of endocrine disease: Can we cure Cushing\u2019s disease? A personal view. Eur J Endocrinol. 2018;178(5):R183\u2013200.","DOI":"10.1530\/EJE-18-0062"},{"key":"2023090109412530079_j_biol-2022-0540_ref_030","doi-asserted-by":"crossref","unstructured":"Barbot M, Zilio M, Scaroni C. Cushing\u2019s syndrome: Overview of clinical presentation, diagnostic tools and complications. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101380.","DOI":"10.1016\/j.beem.2020.101380"},{"key":"2023090109412530079_j_biol-2022-0540_ref_031","doi-asserted-by":"crossref","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol. 2016;4(7):611\u201329.","DOI":"10.1016\/S2213-8587(16)00086-3"},{"key":"2023090109412530079_j_biol-2022-0540_ref_032","doi-asserted-by":"crossref","unstructured":"Clayton RN. Cardiovascular complications of Cushings syndrome: Impact on morbidity and mortality. J Neuroendocrinol. 2022;34(8):e13175.","DOI":"10.1111\/jne.13175"},{"key":"2023090109412530079_j_biol-2022-0540_ref_033","unstructured":"Pizzorno L, Pizzorno J. Subclinical hypercortisolism: An important, unrecognized dysfunction. Integr Med (Encinitas). 2022;21(3):8\u201315."},{"key":"2023090109412530079_j_biol-2022-0540_ref_034","doi-asserted-by":"crossref","unstructured":"Nieman LK. Update on subclinical Cushing\u2019s syndrome. Curr Opin Endocrinol Diabetes Obes. 2015;22(3):180\u20134.","DOI":"10.1097\/MED.0000000000000159"},{"key":"2023090109412530079_j_biol-2022-0540_ref_035","doi-asserted-by":"crossref","unstructured":"Terzolo M, Pia A, Reimondo G. Subclinical Cushing\u2019s syndrome: definition and management. Clin Endocrinol (Oxf). 2012;76(1):12\u20138.","DOI":"10.1111\/j.1365-2265.2011.04253.x"},{"key":"2023090109412530079_j_biol-2022-0540_ref_036","doi-asserted-by":"crossref","unstructured":"Kageyama K, Oki Y, Nigawara T, Suda T, Daimon M. Pathophysiology and treatment of subclinical Cushing\u2019s disease and pituitary silent corticotroph adenomas [Review]. Endocr J. 2014;61(10):941\u20138.","DOI":"10.1507\/endocrj.EJ14-0120"},{"key":"2023090109412530079_j_biol-2022-0540_ref_037","doi-asserted-by":"crossref","unstructured":"Kageyama K, Moriyama T, Sakihara S, Kawashima S, Suda T. A case of preclinical Cushing\u2019s disease, accompanied with thyroid papillary carcinoma and adrenal incidentaloma. Endocr J. 2003;50(3):325\u201331.","DOI":"10.1507\/endocrj.50.325"},{"key":"2023090109412530079_j_biol-2022-0540_ref_038","doi-asserted-by":"crossref","unstructured":"Kageyama K, Oki Y, Sakihara S, Nigawara T, Terui K, Suda T. Evaluation of the diagnostic criteria for Cushing\u2019s disease in Japan. Endocr J. 2013;60(2):127\u201335.","DOI":"10.1507\/endocrj.EJ12-0299"},{"key":"2023090109412530079_j_biol-2022-0540_ref_039","doi-asserted-by":"crossref","unstructured":"Ebisawa T, Tojo K, Tajima N, Kamio M, Oki Y, Ono K, et al. Immunohistochemical analysis of 11-beta-hydroxysteroid dehydrogenase type 2 and glucocorticoid receptor in subclinical Cushing\u2019s disease due to pituitary macroadenoma. Endocr Pathol. 2008;19(4):252\u201360.","DOI":"10.1007\/s12022-008-9052-0"},{"key":"2023090109412530079_j_biol-2022-0540_ref_040","doi-asserted-by":"crossref","unstructured":"Ioachimescu AG, Eiland L, Chhabra VS, Mastrogianakis GM, Schniederjan MJ, Brat D, et al. Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery. 2012;71(2):296\u2013303; discussion 4.","DOI":"10.1227\/NEU.0b013e318257c1f0"},{"key":"2023090109412530079_j_biol-2022-0540_ref_041","doi-asserted-by":"crossref","unstructured":"Masri-Iraqi H, Robenshtok E, Tzvetov G, Manistersky Y, Shimon I. Elevated white blood cell counts in Cushing\u2019s disease: association with hypercortisolism. Pituitary. 2014;17(5):436\u201340.","DOI":"10.1007\/s11102-013-0522-0"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/biol-2022-0540\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/biol-2022-0540\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T09:57:32Z","timestamp":1693562252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/biol-2022-0540\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2,28]]},"published-print":{"date-parts":[[2023,2,28]]}},"alternative-id":["10.1515\/biol-2022-0540"],"URL":"https:\/\/doi.org\/10.1515\/biol-2022-0540","relation":{},"ISSN":["2391-5412"],"issn-type":[{"type":"electronic","value":"2391-5412"}],"subject":[],"published":{"date-parts":[[2023,1,1]]},"article-number":"20220540"}}